Targeting multiple solid tumor types with anti-CD70 allogeneic CAR-T cells

被引：0

作者：

Dequeant, Mary Lee ^{[1
]}

Karnik, Sushant ^{[1
]}

Padalia, Zinkal ^{[1
]}

Minh Thu Tham ^{[1
]}

Ho, Tony ^{[1
]}

Carson, Julie ^{[1
]}

Terrett, Jonathan A. ^{[1
]}

机构：

[1] Crispr Therapeut, Cambridge, MA USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.SABCS18-3184

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3184

引用

页数：2

共 50 条

[31] CAR-T cells targeting CD38 and LMP1 and anti-tumor activity against NK/T cell lymphoma
Li, Hongwen
Shi, Zhuangzhuang
Gao, Yuyang
Li, Zhaoming
Zhang, Mingzhi
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[32] ROLE OF CAR EXPRESSION LEVELS IN THE ANTI-TUMOR EFFICACY OF CAR-T CELLS
Rodriguez-Marquez, P.
Calleja-Cervantes, M. E.
Serrano, G.
San Martin-Uriz, P.
Vilas-Zornoza, A.
Martin-Mallo, A.
Rodriguez-Diaz, S.
Martinez-Turrillas, R.
Jauregui, P.
Calvino, C.
Inoges, S.
Lopez-Diaz, de Cerio A.
Palacios-Berraquero, M. L.
Rodriguez-Otero, P.
Rifon, J.
Alfonso, A.
Lasarte, J. J.
Lozano, T.
Hernaez, M.
Rodriguez-Madoz, J. R.
Prosper, F.
HAEMATOLOGICA, 2021, 106 (10) : 58 - 59
[33] CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
Davenport, Alexander J.
Jenkins, Misty R.
Cross, Ryan S.
Yong, Carmen S.
Prince, H. Miles
Ritchie, David S.
Trapani, Joseph A.
Kershaw, Michael H.
Darcy, Phillip K.
Neeson, Paul J.
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (05) : 483 - 494
[34] Improving the anti-solid tumor efficacy of CAR-T cells by inhibiting adenosine signaling pathway
Li, Na
Tang, Na
Cheng, Chen
Hu, Tao
Wei, Xiaofei
Han, Weidong
Wang, Haoyi
ONCOIMMUNOLOGY, 2020, 9 (01):
[35] Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
Ambrose, Christine
Su, Lihe
Wu, Lan
Dufort, Fay J.
Sanford, Thomas
Birt, Alyssa
Hackel, Benjamin J.
Hombach, Andreas
Abken, Hinrich
Lobb, Roy R.
Rennert, Paul D.
PLOS ONE, 2021, 16 (03):
[36] Advances in CD19-targeting CAR-T cell therapies for multiple myeloma
Steinhardt, Maximilian J.
Einsele, Hermann
Waldschmidt, Johannes M.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2025, 25 (01) : 21 - 25
[37] Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
Panowski, Siler H.
Srinivasan, Surabhi
Tan, Nguyen
Tacheva-Grigorova, Silvia K.
Smith, Bryan
Mak, Yvonne S. L.
Ning, Hongxiu
Villanueva, Jonathan
Wijewarnasuriya, Dinali
Lang, Shanshan
Melton, Zea
Ghosh, Adit
Dusseaux, Mathilde
Galetto, Roman
Heyen, Jonathan R.
Sai, Tao
Van Blarcom, Thomas
Chaparro-Riggers, Javier
Sasu, Barbra
CANCER RESEARCH, 2022, 82 (14) : 2610 - 2624
[38] Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8+T and CAR-T cells
Jo, Yuna
Shim, Ju A.
Jeong, Jin Woo
Kim, Hyori
Lee, So Min
Jeong, Juhee
Kim, Segi
Im, Sun-Kyoung
Choi, Donghoon
Ha Lee, Byung
Kim, Yun Hak
Kim, Chi Dae
Kim, Chan Hyuk
Hong, Changwan
MOLECULAR THERAPY, 2024, 32 (11) : 3879 - 3894
[39] ALLOGENEIC "OFF-THE-SHELF" γδ T CELLS MODIFIED WITH CD27-CONTAINING CAR FOR TARGETING CD70+CANCERS
Lamture, Gauri
Teague, Alexander
Smith-Boeck, Morgan
Salum, Michael
Kaur, Ramandeep
Gundurao, Smitha
Parthasarathy, Pannaga
Chanthery, Yvan
Herrman, Marissa
Aftab, Blake
Bhat, Arun
Nishimoto, Kevin
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A261 - A261
[40] A humanized anti-CD70 monoclonal antibody targets CD70-expressing multiple myeloma.
McEarchern, JA
McDonagh, C
Ho, A
Tai, YT
Francisco, L
Klussman, K
Morris-Tilden, C
Gordon, K
Oflazoglu, E
Kissler, K
Munshi, N
Anderson, KC
Treon, SP
Carter, P
Wahl, AF
Grewal, LS
Law, CL
BLOOD, 2005, 106 (11) : 456A - 456A

← 1 2 3 4 5 →